 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 GLOBE NEWSWIRE -- Atreca, Inc. Atreca NASDAQ: BCEL, a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that it will participate in the following upcoming virtual investor conferences: 